返回 Agenda
Session 4: Enforcement Initiatives by Health Authorities to Ensure Compliance with Clinical Trial Transparency Requirements
Session Chair(s)
Robert Paarlberg, MS
Principal
Paarlberg & Associates LLC, United States
Session 4: Enforcement Initiatives by Health Authorities to Ensure Compliance with Clinical Trial Transparency Requirements
Speaker(s)
![Representative Invited](/_Images/member/Generic_Image_Missing-Profile.jpg)
Speaker
Representative Invited
FDA, United States
![Representative Invited](/_Images/member/Generic_Image_Missing-Profile.jpg)
Representative Invited
Saudi Food and Drug Authority, Saudi Arabia
![Representative Invited](/_Images/member/Generic_Image_Missing-Profile.jpg)
Clinical Trial Regulation, Enforcement, How Member States Think about Harmonization of Transition Trials
Representative Invited
Danish Medicines Agency, Denmark